Showing 3,241 - 3,260 results of 24,535 for search 'LiveAD~', query time: 5.21s Refine Results
  1. 3241

    Acute Liver Failure Caused by ‘Fat Burners’ and Dietary Supplements: A Case Report and Literature Review by Y Radha Krishna, V Mittal, P Grewal, MI Fiel, T Schiano

    Published 2011-01-01
    “…The present report describes a young healthy woman who presented with fulminant hepatic failure requiring emergent liver transplantation caused by a dietary supplement and fat burner containing usnic acid, green tea and guggul tree extracts. …”
    Get full text
    Article
  2. 3242
  3. 3243

    Cutaneous Metastases from Primary Hepatobiliary Tumors as the First Sign of Tumor Recurrence following Liver Transplantation by Adam T. Hauch, Joseph F. Buell, Margit McGowan, Parisha Bhatia, Eleanor Lewin, Mary Killackey, Nathan J. Shores, Luis A. Balart, Martin Moehlen, Bob Saggi, Anil S. Paramesh

    Published 2014-01-01
    “…Cutaneous metastasis from hepatobiliary tumors is a rare event, especially following liver transplantation. We report our experience with two cases of cutaneous metastases from both hepatocellular carcinoma and mixed hepatocellular/cholangiocarcinoma following liver transplantation, along with a review of the literature.…”
    Get full text
    Article
  4. 3244

    Liver Regeneration after Partial Hepatectomy Is Not Impaired in Mice with Double Deficiency of Myd88 and IFNAR Genes by Javier Vaquero, Kimberly J. Riehle, Nelson Fausto, Jean S. Campbell

    Published 2011-01-01
    “…Liver regeneration is known to occur in mice lacking one or more Toll-like receptors (TLRs) or the adaptor protein MyD88. …”
    Get full text
    Article
  5. 3245

    Nutritional education program for fatty liver disease associated with metabolic dysfunction for Primary Health Care physicians by Mirian Belkis Nápoles Valdés, Manuel Horta Sánchez, Miguel Angel Amaró Garrido, Tania Santos

    Published 2024-06-01
    “…Background: insufficiencies in nutritional education by Primary Health Care physicians may influence the inadequate management of fatty liver disease associated with metabolic dysfunction. …”
    Get full text
    Article
  6. 3246

    Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis by Jie Hu, Yani Ke, Fangping Wu, Shan Liu, Conghua Ji, Xiaohong Zhu, Ying Zhang

    Published 2020-01-01
    “…Previous studies have revealed the close relation of irisin with the occurrence and development of nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis were conducted to evaluate the association of circulating irisin levels and NAFLD. …”
    Get full text
    Article
  7. 3247
  8. 3248

    Efficacy of fish oil supplementation on metabolic dysfunction-associated steatotic liver disease: a meta-analysis by Like Zhou, Dongmei Sun, Houqiao Bai

    Published 2025-01-01
    “…ObjectiveGlobally, the occurrence of Metabolic dysfunction-associated steatotic liver disease (MASLD) is on a steady rise. Fish oil has anti-inflammatory effects and can improve lipid metabolism. …”
    Get full text
    Article
  9. 3249
  10. 3250
  11. 3251
  12. 3252
  13. 3253
  14. 3254

    Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure by Lin Lin, Bin Lin, Qing Lan, Longgen Liu, Jianchun Lu, Xiujun Zhang, Shuqin Zheng, Yuan Xue

    Published 2022-01-01
    “…The aim of this study was to provide new insights into the prevalence of positive antinuclear antibody (ANA) in patients with HBV-related acute-on-chronic liver failure (ACLF) and its impact on clinical outcomes. …”
    Get full text
    Article
  15. 3255

    L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle by Roger F. Butterworth

    Published 2019-01-01
    “…Studies in experimental animals and in patients demonstrate that ammonia is directly implicated in the pathogenesis of sarcopenia in cirrhosis via mechanisms involving increased expression of myostatin and of autophagy markers such as LC3 lipidation and p62 leading to muscle dysmetabolism and sarcopenia. Paradoxically, skeletal muscle replaces liver as the primary ammonia-detoxifying site as a result of the modification of genes coding for key proteins implicated in ammonia-lowering pathways in cirrhosis. …”
    Get full text
    Article
  16. 3256

    Sparse Codebook Model of Local Structures for Retrieval of Focal Liver Lesions Using Multiphase Medical Images by Jian Wang, Xian-Hua Han, Yingying Xu, Lanfen Lin, Hongjie Hu, Chongwu Jin, Yen-Wei Chen

    Published 2017-01-01
    “…Characterization and individual trait analysis of the focal liver lesions (FLL) is a challenging task in medical image processing and clinical site. …”
    Get full text
    Article
  17. 3257
  18. 3258

    Therapy with Interleukin-22 Alleviates Hepatic Injury and Hemostasis Dysregulation in Rat Model of Acute Liver Failure by Tariq Helal Ashour

    Published 2014-01-01
    “…The therapeutic efficacy of interleukin-22 (IL-22) on liver injury and hematological disturbances was studied in rat model of acute liver failure (ALF) induced by D-galactosamine/lipopolysaccharide (D-GalN/LPS). …”
    Get full text
    Article
  19. 3259

    Investigation of 23 Bile Acids in Liver Bile in Benign and Malignant Biliary Stenosis: A Pilot Study by Stanislav Rejchrt, Milos Hroch, Rudolf Repak, Tomas Fejfar, Tomas Douda, Darina Kohoutova, Eva Peterova, Jan Bures

    Published 2019-01-01
    “…The aim of this study was to investigate bile acids in liver bile of patients with benign and malignant biliary stenosis and controls without stenosis. …”
    Get full text
    Article
  20. 3260